Rice University won up to $24.8 million over five years from ARPA‑H to develop bioprinted kidney tissues under the PRINT program, aiming to address the organ shortage by advancing engineered renal constructs toward clinical utility. The interdisciplinary effort combines biofabrication, vascularization strategies, and regenerative engineering. The grant supports scaling bioprinted tissues with functional nephrons, perfusable vasculature, and transplantation‑ready constructs, with plans for iterative preclinical testing. Rice’s program seeks modular solutions for organ replacement and for creating transplant‑adjacent tissues to expand donor pools. The award underscores federal interest in regenerative medicine and the potential to accelerate organ engineering through sustained, milestone‑driven funding tied to translational goals.